Explore
Trendline
Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Enhance Mitochondrial Medicine Efforts
Stealth BioTherapeutics Appoints David A. Brown as Chief Scientific Officer to Enhance Mitochondrial Medicine Efforts
Read More
Trendline
Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Read More
Trendline
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advances
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to Board Amid Dravet Syndrome Treatment Advances
Read More
Trendline
Biotech Company Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Biotech Company Scala Biodesign Secures $16M to Expand AI-Driven Protein Development
Read More
Trendline
RoosterBio and MineBio Life Sciences Partner to Enhance MSC and Exosome Bioprocessing in China
RoosterBio and MineBio Life Sciences Partner to Enhance MSC and Exosome Bioprocessing in China
Read More
Trendline
Nuclera Launches Nanodisc Panel to Enhance GPCR Production
Nuclera Launches Nanodisc Panel to Enhance GPCR Production
Read More
Trendline
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License
Read More
Trendline
AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials
AI in Life Sciences Market Projected to Transform Drug Development and Clinical Trials
Read More
Trendline
VION Biosciences Acquires CTL to Enhance Immune Monitoring Capabilities
VION Biosciences Acquires CTL to Enhance Immune Monitoring Capabilities
Read More
Trendline
ABK Biomedical and COR Development to Build Manufacturing Facility in Missouri for Cancer Treatment Device
ABK Biomedical and COR Development to Build Manufacturing Facility in Missouri for Cancer Treatment Device
Read More
Trendline
OneCyte and Kemp Proteins Partner to Enhance Biopharma Cell Line Development
OneCyte and Kemp Proteins Partner to Enhance Biopharma Cell Line Development
Read More
Trendline
Decoy Therapeutics to Host Virtual Investor Event on Business Outlook for 2026
Decoy Therapeutics to Host Virtual Investor Event on Business Outlook for 2026
Read More